Drug Shortage Report for MYLAN-ATORVASTATIN
| Report ID | 57023 |
| Drug Identification Number | 02392933 |
| Brand name | MYLAN-ATORVASTATIN |
| Common or Proper name | ATORVASTATIN |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATORVASTATIN |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 90 BT, 500 BT |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2018-10-11 |
| Actual start date | |
| Estimated end date | 2018-10-19 |
| Actual end date | 2018-10-09 |
| Shortage status | Avoided shortage |
| Updated date | 2018-10-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v19 | 2018-10-09 | French | Compare |
| v18 | 2018-10-09 | English | Compare |
| v17 | 2018-10-03 | French | Compare |
| v16 | 2018-10-03 | English | Compare |
| v15 | 2018-10-03 | English | Compare |
| v14 | 2018-10-01 | French | Compare |
| v13 | 2018-10-01 | English | Compare |
| v12 | 2018-09-24 | French | Compare |
| v11 | 2018-09-24 | English | Compare |
| v10 | 2018-09-20 | French | Compare |
| v9 | 2018-09-20 | English | Compare |
| v8 | 2018-09-13 | French | Compare |
| v7 | 2018-09-13 | English | Compare |
| v6 | 2018-09-13 | French | Compare |
| v5 | 2018-09-13 | English | Compare |
| v4 | 2018-08-30 | French | Compare |
| v3 | 2018-08-30 | English | Compare |
| v2 | 2018-07-31 | French | Compare |
| v1 | 2018-07-31 | English | Compare |
Showing 1 to 19 of 19